Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_assertion type Assertion NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_head.
- NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_assertion description "[Clinical studies in patients with solid tumors using a second-generation antisense oligonucleotide (GEM 231) targeted against protein kinase A type I.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_provenance.
- NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_assertion evidence source_evidence_literature NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_provenance.
- NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_assertion SIO_000772 14751840 NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_provenance.
- NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_assertion wasDerivedFrom befree-2016 NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_provenance.
- NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_assertion wasGeneratedBy ECO_0000203 NP430046.RAVJ646pyqgNRwZwjYcJqnqsKFPtByztL4BIBUVocC2x0130_provenance.